NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 2 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $462,000 | -54.6% | 191,028 | -90.0% | 0.08% | -75.7% |
| Q3 2020 | $1,018,000 | -21.0% | 1,910,287 | 0.0% | 0.32% | -33.9% |
| Q2 2020 | $1,289,000 | +17.4% | 1,910,287 | 0.0% | 0.49% | +2.9% |
| Q1 2020 | $1,098,000 | -56.5% | 1,910,287 | 0.0% | 0.48% | -50.5% |
| Q4 2019 | $2,522,000 | -34.0% | 1,910,287 | 0.0% | 0.97% | -51.5% |
| Q3 2019 | $3,821,000 | -13.1% | 1,910,287 | +5.6% | 1.99% | +6.1% |
| Q2 2019 | $4,396,000 | -0.4% | 1,809,259 | 0.0% | 1.88% | -44.2% |
| Q1 2019 | $4,415,000 | +67.1% | 1,809,259 | 0.0% | 3.36% | +20.8% |
| Q4 2018 | $2,642,000 | – | 1,809,259 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |